However, some recent studies have reported that INPP4B is highly expressed in colon cancer, acute myeloid leukaemia and melanoma, where it serves as an oncogene and is a positively correlated with poor clinical outcomes [17–19]. This evidence concerns the gene INPP4B and malignant colon neoplasm.